ursodeoxycholic acid N-acetylglucosaminide

Known as: Cholan-24-oic acid, 3-((2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl)oxy)-7-hydroxy-, (3alpha,5beta,7beta)-, GlcNAc-UDCA, UDCA-NAGA 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1989-2015
01219892015

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
BACKGROUND & AIMS Polycystic liver diseases (PLDs) are genetic disorders characterized by progressive biliary cystogenesis… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2015
2015
BACKGROUND Hepatic fat accumulation with disturbed lipid homoeostasis is a hallmark of nonalcoholic fatty liver disease (NAFLD… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
2006
2006
Ursodeoxycholic acid exerts anticholestatic effects in chronic cholestatic liver disease in humans as well as in experimental… (More)
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
1995
1995
OBJECTIVES The appearance of gallstone opacification during oral bile acid administration indicates that stones are no longer… (More)
Is this relevant?
1989
1989
We have applied a specific and accurate high pressure liquid chromatographic technique to determine fasting serum glycine and… (More)
Is this relevant?